As a next-generation probiotic, it could signal a shift to targeted microbiome-based therapies, potentially treating a wide range of metabolic and inflammatory disorders
RegenMD prescribes compounded GLP-1 therapy with personalized dosing tailored to your body and goals
N Engl J Med 377:644657 Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes
Thalamocortical dysfunction and dysrhythmia in chronic pain demonstrated that CLBP pathophysiology and clinical pain intensity are associated with distinct thalamocortical network dynamics